Using electronic patient-reported measures to characterize symptoms and improvement in inpatient psychiatric units.


Journal

Psychiatry research
ISSN: 1872-7123
Titre abrégé: Psychiatry Res
Pays: Ireland
ID NLM: 7911385

Informations de publication

Date de publication:
11 2022
Historique:
received: 03 03 2022
revised: 30 08 2022
accepted: 07 09 2022
pubmed: 19 9 2022
medline: 18 11 2022
entrez: 18 9 2022
Statut: ppublish

Résumé

Patient-reported measures are an important tool in personalizing care and monitoring clinical outcomes. This work presents results from the routine collection of self-report measures from individuals (n = 753) admitted to depression and anxiety inpatient units at McLean Hospital. 93.7% participated in the Clinical Measurement Initiative (CMI) between September 2020 and February 2022 on the most established unit. The average time between admission and discharge measures was 12.6 days and an attrition rate of 10.4% was observed on this unit. Missingness of discharge assessments was unrelated to symptom severity or comorbidities. We discuss the feasibility of deploying patient-reported measures as part of routine care in an inpatient psychiatric setting. Systematic evaluation of potential treatment modifiers (e.g., personality disorder, trauma history, and substance misuse) may be valuable in better serving those impacted by psychiatric illness.

Identifiants

pubmed: 36116185
pii: S0165-1781(22)00432-2
doi: 10.1016/j.psychres.2022.114839
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

114839

Informations de copyright

Copyright © 2022. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest Dr. Ressler reports having performed scientific consultation for Bioxcel, Bionomics, Acer, Takeda, and Jazz Pharmaceuticals. He serves on Scientific Advisory Boards for Sage Therapeutics and the Brain Research Foundation, and he has received sponsored research support from Takeda, Brainsway and Alto Neuroscience. None of these roles are related to the current publication.

Auteurs

Samantha A Wong (SA)

Division of Depression and Anxiety, McLean Hospital, Belmont, MA, United States of America.

Lucie A Duffy (LA)

Division of Depression and Anxiety, McLean Hospital, Belmont, MA, United States of America.

Savannah D Layfield (SD)

Division of Depression and Anxiety, McLean Hospital, Belmont, MA, United States of America.

Marina Long (M)

Division of Depression and Anxiety, McLean Hospital, Belmont, MA, United States of America; Department of Psychiatry, Harvard Medical School, Boston, MA, United States of America.

Fernando Rodriguez-Villa (F)

Division of Depression and Anxiety, McLean Hospital, Belmont, MA, United States of America; Department of Psychiatry, Harvard Medical School, Boston, MA, United States of America.

Steven E Gelda (SE)

Division of Depression and Anxiety, McLean Hospital, Belmont, MA, United States of America; Department of Psychiatry, Harvard Medical School, Boston, MA, United States of America.

Eliot M Gelwan (EM)

Division of Depression and Anxiety, McLean Hospital, Belmont, MA, United States of America; Department of Psychiatry, Harvard Medical School, Boston, MA, United States of America.

Dawn E Sugarman (DE)

Department of Psychiatry, Harvard Medical School, Boston, MA, United States of America; Division of Alcohol, Drugs, and Addiction, McLean Hospital Belmont, MA, United States of America.

Alisa Busch (A)

Department of Psychiatry, Harvard Medical School, Boston, MA, United States of America; McLean Hospital and Department of Health Care Policy, Harvard Medical School Boston, MA, United States of America.

Jane Eisen (J)

Division of Depression and Anxiety, McLean Hospital, Belmont, MA, United States of America; Department of Psychiatry, Harvard Medical School, Boston, MA, United States of America.

Kerry J Ressler (KJ)

Division of Depression and Anxiety, McLean Hospital, Belmont, MA, United States of America; Department of Psychiatry, Harvard Medical School, Boston, MA, United States of America.

Agustin G Yip (AG)

Division of Depression and Anxiety, McLean Hospital, Belmont, MA, United States of America; Department of Psychiatry, Harvard Medical School, Boston, MA, United States of America. Electronic address: ayip@mclean.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH